NCT04828226View on ClinicalTrials.gov

Clonidine to Prevent Delirium After Electroconvulsive Therapy.

PHASE4RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

July 27, 2026

Study Completion Date

July 31, 2026

Conditions
Major Depressive DisorderCatatoniaBipolar DisorderDelirium Postseizure
Interventions
DRUG

Clonidine

Clonidine 2mcg/kg Body Weight diluted in 100ml sodium chloride 0.9% compared to placebo (sodium chloride 0.9% alone) given over 10 minutes, 10 minutes prior to electroconvulsive therapy.

DRUG

Placebo

Sodium chloride 0.9% 100ml given over 10minutes, 10 minutes prior to electroconvulsive therapy.

Trial Locations (1)

3010

RECRUITING

Department of Anaesthesiology and Pain Medicine, Bern University Hospital, University of Bern, Bern

All Listed Sponsors
collaborator

University of Bern

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER